drugset
drugset / Trial / NCT00727129

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

NCT00727129 ↗

Phase 3 Completed 495 enrolled Upsher-Smith Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the safety and efficacy of USL-221 to placebo for postmenopausal patients.

Timeline

Start
2004-07
Primary completion
—
Completion
2005-08

Publications

  • Results Hedrick RE. Low-dose estradiol gel 0.1% for the treatment of vasomotor symptoms associated with menopause. Expert Review of Obstetrics & Gynecology, 3(2): Pages 155-162, Mar 2008.

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified — —

Indications

No indication recorded.